* Discovery and development of novel therapeutic agents from synthetic/natural sources for cancer, cardioprotection and, for neurodegenerative diseases

* Discovery and development of novel NLRP3 inflammasome inhibitors from the synthetic and natural sources for the treatment of inflammatory and neurodegenerative diseases.

* Design and synthesis of novel small molecules as anticancer, anti-diabetic, anti-inflammatory, anti-Helicobacter pylori agents. * Isolation and structure identification of novel small molecules from plants and microorganism for a diverse range of therapeutic areas including inflammation, cancer, diabetic, neuroscience, and Helicobacter pylori-associated gastric inflammation, etc. * Analytical methods development, optimization and validation of small molecule analyses from medicinal plants/microorganism using HPLC and Capillary electrophoresis (CE). * Development of bioengineering processes for the enhanced production of extracellular protease, cyclohexadepsipeptides, bacterial spore’s production, and cyclic lipopeptide antibiotics.